Lithoclast
Payments companies reported to CMS as associated with Lithoclast. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lithoclast, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lithoclast
These are the largest totals companies reported as associated with Lithoclast. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Julio Davalos | Glen Burnie, MD | Urology | $1,481.28 |
| Natalia Arias Villela | Towson, MD | Urology | $578.13 |
| Raymond Khargi | Brooklyn, NY | Urology | $332.99 |
| Jeffrey Orf | Fenton, MO | Urology | $319.82 |
| Sriharan Sivalingam | Cleveland, OH | Urology | $311.97 |
| Meagan Dunne | Towson, MD | Urology | $278.07 |
| Seth Teplitsky | Durham, NC | Urology | $271.35 |
| Hannah Jarvis | Birmingham, AL | $271.34 | |
| William Atallah | Brooklyn, NY | Urology | $252.39 |
| Mantu Gupta | New York, NY | $252.39 |
Prescribed Lithoclast?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.